This effect is likely related to impaired hepatic clearance in cirrhosis, leading to drug accumulation and excessive FXR activation, which can worsen portal hypertension and cholestatic injury in vulnerable livers [32]. The gene discussed is NR1H4; the disease is Cirrhosis.